Click on image to view larger version.

Figure 2 (a) Pre- and post-treatment resting flow values in patients treated with angiotensin-receptor blockers (ARBs). (b) Pre- and post-treatment maximal flow values in patients treated with ARBs. (c) Pre- and post-treatment myocardial perfusion reserve in patients treated with ARBs.